Cabergoline standard dosage and daily medication guide

Cabergoline is a selective dopamine D2 receptor agonist, mainly used to treat hyperprolactinemia, hyperprolactinemia caused by pituitary tumors, and some symptoms of Parkinson's disease. It activates dopamine receptors and inhibits the secretion of prolactin from the pituitary gland, thereby improving symptoms such as menstrual disorders, infertility, and galactorrhea caused by hyperprolactinemia. When using cabergoline, following standard dosage and correct administration are key to ensuring efficacy and safety.

In patients with hyperprolactinemia, the starting dose of cabergoline is usually 0.25mg to 0.5mg, taken in divided doses or taken orally once, gradually increase according to the patient's tolerance, and the weekly dose can be adjusted to 1–2mg. Dosage adjustments should be made under the guidance of a doctor, usually after assessing blood prolactin levels and clinical symptoms every 4 weeks before deciding whether to increase the dose to avoid adverse reactions such as hypotension, dizziness or nausea.

In terms of daily medication guidelines, cabergoline should be taken orally at the same time, preferably with meals to reduce gastrointestinal irritation. Patients should maintain regular medication and avoid increasing or decreasing the dose on their own or stopping medication at will. If you miss a dose, you can take it as soon as you remember it that day. However, if it is close to the next dose time, skip the missed dose and do not take double dose. Dizziness, fatigue or mild nausea may occur at the beginning of treatment. Most patients' symptoms will be relieved after a few days of adaptation.

Patients taking cabergoline for a long time should have their blood prolactin levels, heart function, and liver function checked regularly, especially those with a history of heart valve disease. For pregnant women or those planning pregnancy, the dosage should be adjusted or discontinued under the guidance of a doctor. In short, standard medication, regular monitoring and dose adjustment according to doctor's instructions are key measures to ensure the safe and effective treatment of hyperprolactinemia with cabergoline, which can help improve symptoms and reduce the risk of recurrence.

Reference materials:https://www.drugs.com/